Cargando…
P20 Novel phenotypic, impedance-based fast antibiotic susceptibility test (AST) can distinguish between MRSA and MSSA in 2 h
BACKGROUND: Antimicrobial resistance (AMR) is a global problem and is forecast that by 2050 it will cause 10 million deaths a year. Current antimicrobial susceptibility tests (ASTs) used clinically, can take 24–48 h or longer to report results, requiring that initial treatment uses broad spectrum an...
Autor principal: | Martin, Bethany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848847/ http://dx.doi.org/10.1093/jacamr/dlac133.024 |
Ejemplares similares
-
Characterization of Heterogeneous MRSA and MSSA with Reduced Susceptibility to Chlorhexidine in Kuwaiti Hospitals
por: Vali, Leila, et al.
Publicado: (2017) -
193. Comparison of Survival for MSSA and MRSA Endocarditis
por: Kanyo, Emese, et al.
Publicado: (2019) -
Proteomic profiling of the endogenous peptides of MRSA and MSSA
por: Tu, Haixia, et al.
Publicado: (2021) -
Pyrazolyl Thioureas and Carbothioamides with an NNSN
Motif against MSSA and MRSA
por: Delpe-Acharige, Anjana, et al.
Publicado: (2021) -
Efficiency of Antimicrobial Photodynamic Therapy with Photodithazine(®) on MSSA and MRSA Strains
por: Souza, Beatriz Müller Nunes, et al.
Publicado: (2021)